Wound Panel

Firmalab’s state-of-the-art Real-Time RT-PCR molecular test offers comprehensive detection of 28 bacterial, fungal, and viral pathogens associated with various wound types. Our panel also screens for 28 antibiotic resistance genes, providing clinicians with crucial insights to make targeted, data-driven treatment decisions for improved patient outcomes.

WHO WE SERVE

Firmlab Bio-Diagnostics is equipped to handle high-volume testing with rapid turnaround times, making us an ideal partner for hospitals, long-term facilities, home health providers, podiatrists, urgent care centers, surgical units, military medical facilities, correctional healthcare and research institutions with advanced wound infection testing for precise pathogen detection and antibiotic resistance analysis.

Wound Pathogen RT-PCR Targets

Bacteria

Escherichia coli
Streptococcus agalactiae
Klebsiella oxytoca
Staphylococcus saprophyticus
Pseudomonas aeruginosa
Klebsiella pneumoniae
Staphylococcus haemolyticus
Enterococcus faecium
Enterococcus faecalis
Acinetobacter calcoaceticus-baumannii complex
Staphylococcus aureus
Streptococcus pyogenes
Streptococcus pneumoniae
Staphylococcus dysgalactiae
Staphylococcus epidermidis

Fungi

Candida krusei
Candida tropicalis
Candida glabrata
Candida parapsilosis
Candida albicans
Fusarium solani
Microsporum spp
Trichophyton spp

Viruses

Collection methods

We use ESwab® Liquid Based Collection and Transport Collection which allows comfort and stability for transport preservation of aerobic, anaerobic and fastidious Bacteria

Wound ESwab

Turnaround time: 24 – 48 hours
Sensitivity: 97.10% at 3 copies/ul
Specificity: 99.30% at 3 copies/ul
Methodology: RT-PCR Molecular Assay

Diagnostic testing, infection control, and patient management

Monitoring of long-term care patients, infection control, and routine health screenings.

Fast, precise pathogen detection and antibiotic resistance analysis to support effective treatment for combat wounds and military healthcare needs.

Rapid, precise pathogen detection and antibiotic resistance analysis to support infection prevention and post-surgical patient care.

Antibiotic Resistance Detection with PharmD Guidance

Firmalab offers advanced UTI molecular diagnostics using Real-Time PCR technology, delivering same-day results with superior accuracy over traditional culture methods.

Antibiotic Resistance Detection

Accurately detects key antibiotic resistance genes, guiding the selection of the most effective treatment.

Our UTI Pathogen Detection and Antibiotic Resistance Molecular Assay is performed on open array platform, and is designed to serve as an alternative to traditional urine culture and antibiotic sensitivity testing. This assay is particularly beneficial for symptomatic patients, acting as a reflex to abnormal urine chemistry and microscopic findings, aiding in the accurate diagnosis and effective management of UTIs.

Antibiotic Resistance Genes Tested

KPC - Class A Carbapenemases
VIM - Class B Carbapenemases
NDM - Class B Carbapenemases
IMP - Class B Carbapenemases
QNR - Quinolones/Fluoroquinolones
OXA - Class D Carbapenemases
mecA/C - Penicillins
Van A - Vancomycin
Van B - Vancomycin
Sul 1-2 - Sulfonamides
Ctx - Cephalosporins
DfrA - Diaminopyrimidines/Trimethoprim

SHV - ESBLs
ermA - Erythromycin
ermB - Erythromycin
ermC - Erythromycin
DHA - Quinolones/Fluoroquinolones
OXA - β-lactamases
APH(3′)-Ia - Aminoglycoside
FOX - β-lactamases
VEB - β-lactamases
AAC(3)-IV - Aminoglycoside
GES - GES-type ESBLs
TET - Tetracycline
aadA - Aminoglycoside
ANT(2) - Aminoglycoside

PharmD Guidance Reporting

We offer PharmD guidance with our ABR detection. We use a intelligent software for analyzing and interpretation of syndromic panels and antibiotic resistance testing. Using a proprietary algorithm and scoring system, we recommend the most appropriate medications and dosages based on laboratory results and current clinical guidelines.